Analyst Ratings For Exelixis - Nasdaq

Oct 21, 2024 · Stay up to date on Exelixis analyst ratings. Unveiling the Story Behind Exelixis Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer.

$37.13
OFF

15 Analysts Have This To Say About Exelixis - Exelixis (NASDAQ:EXEL)

2 weeks from now

1 day ago · In the assessment of 12-month price targets, analysts unveil insights for Exelixis, presenting an average target of $37.13, a high estimate of $42.00, and a low estimate of $29.00.

benzinga.com

$40.00
OFF

Exelixis (NASDAQ:EXEL) Stock, Analyst Ratings, Price Targets

2 weeks from now

6 days ago · The latest price target for Exelixis (NASDAQ:EXEL) was reported by HC Wainwright & Co. on January 10, 2025. The analyst firm set a price target for $40.00 expecting EXEL to …

benzinga.com

00%
OFF

Exelixis, Inc. (EXEL) Stock Forecast & Price Targets - Stock Analysis

2 weeks from now

Jan 7, 2025 · NASDAQ: EXEL · Real-Time Price · USD. Watchlist Compare. 35.30-0.72 (-2.00%) At close: Jan 13, 2025, 4:00 PM. 34.87 ... Analyst Ratings. The average analyst rating for …

stockanalysis.com

$25.64
OFF

14 Analysts Have This To Say About Exelixis | Markets Insider

2 weeks from now

Oct 11, 2023 · These 14 analysts have an average price target of $25.64 versus the current price of Exelixis at $21.57, implying upside. Below is a summary of how these 14 analysts rated …

businessinsider.com

$23.00
OFF

Exelixis (NASDAQ:EXEL) Hits New 52-Week High On Analyst Upgrade

2 weeks from now

11 hours ago · A number of other brokerages have also recently weighed in on EXEL. Stephens lifted their price objective on shares of Exelixis from $23.00 to $29.00 and gave the company …

marketbeat.com

$32.53
OFF

Expert Outlook: Exelixis Through The Eyes Of 19 Analysts - Nasdaq

2 weeks from now

Dec 17, 2024 · Analysts have set 12-month price targets for Exelixis, revealing an average target of $32.53, a high estimate of $39.00, and a low estimate of $27.00.

nasdaq.com

$29.00
OFF

Exelixis (NASDAQ:EXEL) Stock Price Expected To Rise, JMP

2 weeks from now

16 hours ago · Finally, HC Wainwright raised their price target on Exelixis from $29.00 to $40.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. One …

marketbeat.com

$25.00
OFF

Barclays Sticks To Its Hold Rating For Exelixis (EXEL)

2 weeks from now

3 days ago · Barclays analyst Peter Lawson maintained a Hold rating on Exelixis (EXEL – Research Report) today and set a price target of $25.00. The company’s shares closed last …

businessinsider.com

$42.00
OFF

Exelixis (NASDAQ:EXEL) Price Target Raised To $42.00 - MarketBeat

2 weeks from now

16 hours ago · Exelixis (NASDAQ:EXEL - Get Free Report) had its price target increased by Truist Financial from $38.00 to $42.00 in a report released on Wednesday,Benzinga reports. …

marketbeat.com

$42
OFF

Exelixis Price Target Raised To $42 From $38 At Truist

2 weeks from now

1 day ago · Truist raised the firm’s price target on Exelixis to $42 from $38 and keeps a Buy rating on the shares after its positive Q4 pre-announcement.The firm views the stock favorably, and …

businessinsider.com

90%
OFF

Why Exelixis (EXEL) Is Poised To Beat Earnings Estimates Again

2 weeks from now

1 day ago · For the last reported quarter, Exelixis came out with earnings of $0.47 per share versus the Zacks Consensus Estimate of $0.42 per share, representing a surprise of 11.90%.

nasdaq.com

$41
OFF

Exelixis Price Target Raised To $41 From $34 At JMP Securities

2 weeks from now

1 day ago · JMP Securities raised the firm’s price target on Exelixis to $41 from $34 and keeps an Outperform rating on the shares.Exelixis provided preliminary fiscal year 2024 financial results …

businessinsider.com

FAQs about Analyst Ratings For Exelixis - Nasdaq Coupon?

Should you buy Exelixis stock?

The average analyst rating for Exelixis stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP. Sources: Price targets and analyst ratings provided by Benzinga. ...

What are Exelixis analyst ratings?

Stay up to date on Exelixis analyst ratings. Analyst Ratings: What Are They? Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). ...

How much should you buy Exelixis (Exe)?

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for Exelixis, revealing an average target of $26.4, a high estimate of $28.00, and a low estimate of $25.00. ...

How do analysts evaluate Exelixis?

Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Exelixis compared to the broader market. Price Targets: Understanding forecasts, analysts offer estimates for Exelixis's future value. ...

What was Exelixis' stock price on January 1st 2024?

Exelixis' stock was trading at $23.99 on January 1st, 2024. Since then, EXEL shares have increased by 49.3% and is now trading at $35.82. How were Exelixis' earnings last quarter? Exelixis, Inc. (NASDAQ:EXEL) released its quarterly earnings results on Tuesday, October, 29th. ...

Where is Exelixis headquartered?

The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA. Barclays analyst Peter Lawson maintained a Hold rating on Exelixis (EXEL – Research Report) today and set a price target of $25.00. ...